Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
Thursday, September 12, 2024Eliem Therapeutics Inc announced today members of the management team will participate at the Stifel Virtual Immunology and Inflammation Summit being held September
Sino Biological and BioGeometry Deepen Strategic Cooperation to Empower Protein R&D with Generative AI
Thursday, September 12, 2024Sino Biological a leading recombinant protein production company is pleased to announce an expansion of its strategic partnership with BioGeometry a pioneer in digital biology This collaboration brings together Sino Biologicals advanced protein expre...
BridgeBio Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for BBP-812 Canavan Disease Gene Therapy Program
Wednesday, September 11, 2024BridgeBio Pharma Inc a commercialstage biopharmaceutical company focused on genetic diseases today announced that the United States Food and Drug Administration FDA has granted Regenerative Medicine Advanced Therapy
Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2
Tuesday, September 10, 2024Evaxion Biotech AS a clinicalstage TechBio company specializing in developing AIImmunology powered vaccines announces new preclinical data demonstrating the ability of its novel EVXB mRNA Gonorrhea vaccine candidate in eliminating
TILT Biotherapeutics Presents Clinical Data on TILT-123 After Fully Intravenous Delivery Regimen at ESMO 2024
Tuesday, September 10, 2024TILT Biotherapeutics TILT a clinicalstage biotechnology company developing cancer immunotherapies announces that it will present data at the European Society of Medical Oncology ESMO Congress The results further demonstrate the potential for TILT as...
Next-generation TFF cassette, Vivaflow® SU, delivers intuitive, effortless, and sustainable ultrafiltration to research scientists
Monday, September 09, 2024The life science group Sartorius is launching Vivaflow SU setting a new standard for laboratorydedicated tangential flow filtration TFF Designed for enhanced ease of use and flexibility Vivaflow SU ensures more efficient
Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results
Friday, September 06, 2024Boehringer Ingelheim and CDRLife today announce positive results from the Phase I evaluation of BI Study Record ClinicalTrialsgov an investigational antibody fragment developed to preserve vision in people living with geographic atrophy GA BI
Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14
Friday, September 06, 2024Voyager Therapeutics Inc a biotechnology company dedicated to advancing neurogenetic medicines today announced that Novartis AG NYSE NVS has agreed to license a novel capsid generated from Voyagers TRACER capsid discovery platform
QIAGEN and Lilly collaborate to support development of a QIAstat-Dx IVD panel that identifies patients at risk for developing Alzheimer’s disease
Thursday, September 05, 2024QIAGEN announced it has entered into a collaboration with Eli Lilly and Company to support the development of a QIAstatDx invitro diagnostic IVD to detect APOE genotypes which can play a role in the diagnosis of Alzheimers disease This collaboration
ADVANZ PHARMA secures temporary suspension of the European Commission decision on the OCALIVA® conditional marketing authorisation in Europe
Thursday, September 05, 2024ADVANZ PHARMA Holdco Limited a UK headquartered pharmaceutical company today announces that the General Court of the European Union General Court has temporarily suspended the European Commission EC decision to revoke the conditional
